Patents
Sitemap › C07 - Organic chemistry › C07J - Steroids › C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
12/2003
12/30/2003US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds
12/30/2003US6670393 Carbamate-based cationic lipids
12/30/2003US6670353 Oxime-group containing oestrone sulphatase inhibitors
12/30/2003CA2098146C Process for the preparation of 20-keto-21-alpha-hydroxy steroids and intermediates
12/25/2003US20030236408 Estrogenic compounds as anti-mitotic agents
12/18/2003WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen
12/18/2003WO2003038523A3 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties
12/18/2003WO2002090375A3 Liver x receptor agonists
12/18/2003US20030232791 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
12/17/2003CN1131235C 11'beta-halogen-7alpha-substd estratrienes, Preparation of Pharmaceutical preparation containing 11'beta'-halogen-7alpha-substd estratrienes
12/11/2003US20030229037 Novel cationic amphiphiles
12/10/2003EP1077992B1 Use of meiosis regulating compounds
12/10/2003EP0671924B1 Digitalis-like compounds
12/04/2003WO2003070194A3 Amino acid and peptide-modified forms of glucocorticoids
12/04/2003US20030225051 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
12/04/2003US20030225050 Process for production of crystals of 11ss-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
12/04/2003US20030224348 Methods of screening for SCAP antagonists
12/04/2003US20030224347 Pharmaceutical compositions
12/03/2003CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
12/02/2003CA2118565C Process for the preparation of 3.beta.-aminocholanic acid derivatives
11/2003
11/27/2003WO2002062302A3 Steroidal derivatives
11/26/2003EP1363933A2 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
11/26/2003EP1363932A2 Amphoteric sterols and the use thereof
11/25/2003US6652834 Tensioactive properties, long lasting activity in the blood pool
11/20/2003WO2003095471A2 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/20/2003WO2003070745A3 Carbonate and carbamate modified forms of glucocorticoids
11/20/2003US20030216362 Estra-1,3,5 (10)-triene derivatives
11/20/2003US20030216360 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension.
11/20/2003US20030215516 Wet milling saturated solutions containing drugs such as steroids, while crystallizing to obtain microstructure particles in suspension
11/20/2003CA2485146A1 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP0857173B1 Meiosis regulating compounds
11/13/2003US20030212051 Bile acid containing prodrugs with enhanced bioavailabilty
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645953 Meiosis regulating compounds
11/06/2003WO2003091272A1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations
11/06/2003WO2003090721A2 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations
11/06/2003WO2003090714A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations
11/06/2003WO2003027132A3 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES
11/06/2003US20030207431 Properties of mycophenolic acid inhibition of IMPDH (inosine-5'-monophosphate dehydrogenase) that allow the development of the immunoassay; drug conjugates with an uncompetitive inhibitor of IMPDH, mycophenolic acid
11/06/2003CA2480130A1 Method for producing crystals from active ingredients in medicaments and the use thereof in pharmaceutical formulations
11/05/2003EP1358201A1 A process for the preparation of 3-glutamido bile ester derivatives using n-protected methyl pyroglutamate
11/04/2003US6642397 Steroid sulphatase inhibitors
11/04/2003US6642220 Inhibiting estrone sulfatase without administering estrogenic compound by administering to subject sulfamate compound which is nonestrogenic in uterine growth test
10/2003
10/30/2003WO2003089449A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/30/2003WO2003053365A3 Syn3 compositions and methods
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/29/2003CN1452617A Acid-sensitive compounds, preparation and uses thereof
10/29/2003CN1452498A 药物活性化合物 Pharmaceutically active compounds
10/28/2003US6638923 Estra-1,3,5(10),16-tetraene derivatives
10/23/2003WO2003087121A1 Branched polyamine steroid derivatives
10/23/2003WO2003086303A2 Farnesoid x-activated receptor agonists
10/23/2003CA2482195A1 Farnesoid x-activated receptor agonists
10/23/2003CA2479714A1 Branched polyamine steroid derivatives
10/22/2003CN1450080A Novel steroid compound and extraction process thereof
10/22/2003CN1125077C Sulphamate derivatives of 1,3,5(10)-estratriene derivatives methods of producing them and pharmaceutical compounds containing them
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003CA2072053C 16-methyl substituted steroids derived from pregna 1,4-diene 3,20-dione, their preparation and application to the preparation of 16-methylene steroids and novel intermediate compounds
10/16/2003WO2002079220A3 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
10/16/2003US20030194372 Radioimaging probes and the use thereof
10/15/2003EP1351972A1 Lipids comprising an aminoxy group
10/09/2003US20030191099 Antiestrogen compound
10/02/2003WO2003080642A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring
09/2003
09/30/2003US6627218 Cationic lipid with a lipophilic group derived from cholesterol; an amide or carbamate linker bond; an alkylene spacer arm; and a cationic primary, secondary, tertiary or quaternary amino group. facilitating nucleic acid transfer
09/30/2003CA2114630C Steroid sulphatase inhibitors
09/25/2003US20030181742 Process for the preparation of pregnane derivatives
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/23/2003CA2218555C Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
09/23/2003CA2062973C Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia
09/18/2003US20030176407 Carbonate and carbamate modified forms of glucocorticoids
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/17/2003EP1343803A2 2-substituted estrogens as antiangiogenic agents
09/17/2003EP1343485A2 Lipid-based nitric oxide donors
09/17/2003EP1009755B1 Steroid sulfatase inhibitors and methods for making and using the same
09/16/2003US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
09/16/2003CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
09/11/2003US20030171576 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone.
09/11/2003US20030171346 Safe method for the production of sulfamoyl chloride from chlorosulfonyl isocyanate and formic acid in the presence of a amide catalyst, taming the hazardous nature of this reaction by circumventing heat accumulation processes, as well as the
09/11/2003US20030170216 SYN3 compositions and methods
09/10/2003EP1341805A1 Method for the production of 4-(17$g(a)-alkoxymethyl-17$g(b)-substituted 3-oxoestra-4,9-dien-11$g(b)-yl)benzaldehyd-(1e)-oxime derivatives
09/10/2003CN1441678A Compounds with sulphonamide group and pharmaceutical compositions containing these compounds
09/04/2003WO2003072109A1 Use of biogenic estriol sulfamate prodrugs for the treatment of autoimmune diseases
09/04/2003US20030166150 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
09/03/2003EP1339734A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes
09/03/2003EP1339733A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes
09/03/2003EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
09/03/2003EP0775156B1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives
08/2003
08/28/2003WO2003070745A2 Carbonate and carbamate modified forms of glucocorticoids
08/28/2003WO2003070194A2 Amino acid and peptide-modified forms of glucocorticoids
08/27/2003CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group
08/26/2003US6610866 Reacting unsaturated alkyl ketone with chiral oxazaborolidine compound to form unsaturated alkyl alcohol; intermediates for production of squalamine
08/26/2003US6610844 Removing an 11-alpha-leaving group from an epoxymexrenone derivative
08/26/2003US6610676 Nitrate esters of corticoid compounds and pharmaceutical applications thereof
08/21/2003WO2003068736A2 Mixed steroidal 1,2,4,5-tetraoxane compounds and methods of making and using thereof
08/21/2003US20030158164 Novel antiandrogenic agent
08/21/2003US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds
08/20/2003EP1335928A1 Selective glucocorticoid receptor agonists
08/14/2003US20030153545 Methods of making 21-[4'-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
08/14/2003US20030153543 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
08/13/2003CN1117759C Steroid, its preparation method, medicine composition and use thereof
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 47